Highlights from the conference, held this past week in San Diego, included new research and clinical tips on stopping Barrett's esophagus surveillance, diet and environmental risk factors in patients with
New evidence supports closer follow-up for some patients and less surveillance for others, according to a task force of the American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal
The increase primarily occurred among people who reported drug use or homelessness.
A Taiwanese nationwide cohort study of more than 10,000 patients with chronic hepatitis B showed a statistically significant 29% risk reduction for hepatocellular carcinoma in patients who received daily aspirin compared with matched controls.
A survey of internists showed that 79% inappropriately recommended stopping proton-pump inhibitors (PPIs) in a prevention scenario focusing on high-risk upper gastrointestinal bleeding.
Rates of clinical remission and clinical response were 32.0% and 42.7%, respectively, in Crohn's disease patients receiving therapy with both corticosteroids and anti-tumor necrosis factor (TNF) agents and 35.5% and 46.8% in those receiving only anti
For postexposure prophylaxis, the hepatitis A vaccine is now preferred to immune globulin for all adults, including those older than 40 years of age, the Advisory Committee on Immunization Practices (ACIP) said.
Odds of inadequate cleansing were higher in patients who were bedridden or constipated, those with diabetes, those taking antipsychotic drugs, and those hospitalized for seven days or longer.
A retrospective cohort study looked at patients with cirrhosis who were enrolled in Medicare and had had more than four outpatient visits over 180 days.
A Korean cohort study did not find any association between use of proton-pump inhibitors (PPIs) and risk of infection with SARS-CoV-2, but current use was associated with higher risk of a composite endpoint that included ICU admission, mechanical